Veryan Medical has announced that the first subject has been enrolled in its MIMICS-2 study at Universitäts-Herzzentrum Freiburg in Bad Krozingen, Germany, by the European principal investigator, Thomas Zeller.
The first clinical cases using Lombard Medical’s new Aorfix Plus endovascular stent graft have been successfully completed.
Jan Heyligers and Patrick Vriens, Tilburg, The Netherlands, write about a technique using the great saphenous vein for the reconstruction of an infected aorta. The technique, defined as a “see one, do one” procedure, was presented at the Charing Cross Symposium in April.
The widely varying progressions of cancer require comprehensive diagnostics, an early check of treatment, and the exchange of information with colleagues. Siemens says that its new version of the diagnostics software syngo.via supports the treating physician in making decisions regarding treatment in oncology through a comprehensive portfolio of applications across imaging systems, treatments, and disciplines.
Hansen Medical has announced it will exhibit its Magellan Robotic System at the Global Embolization Symposium and Technologies (GEST) Scientific Meeting 24–27 June at the FIBES II New Conference Centre in Seville, Spain.
While there is a trend towards using smaller sized particles to obtain better results with embolization, clinical and research experts at the recently held Global Embolization Symposium and Technologies (GEST EU; 24–27 June, Seville, Spain) agreed that there appeared to be a lower size limit, <100µm, below which drug-eluting beads did not have an effective embolic effect.
A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings could help better manage patients symptoms.
A petite 44-year-old woman has received a successful heart transplant at Ronald Reagan UCLA Medical Center, thanks to an experimental Total Artificial Heart designed for smaller patients. The UCLA patient is the first person in California to receive the smaller Total Artificial Heart, and the first patient in the world with the device to be bridged to a successful heart transplant - that is, to go from needing a transplant to receiving one.
A new algorithm created by engineering experts at the University of Lincoln, UK, provides more effective Electrocardiogram (ECG) diagnosis for people with heart conditions. The research, which improves ECG signal classification and improved abnormality detection and diagnosis, won an award at the recent International Conference on Medical and Health Science held in Berlin.
Patients are experiencing significant delays in access to approved cardiovascular devices due to bureaucratic inefficiencies, reveals a Devices White Paper from the Cardiovascular Round Table (CRT) published July 1 in European Heart Journal.
In the largest multi-institutional study to date, patients diagnosed with bladder cancer and treated with robot-assisted surgery experienced similar results to those who underwent a traditional open operation, according to research led by scientists at Roswell Park Cancer Institute (RPCI). The study results were recently published in the journal of the European Association of Urology.
Chemists at Caltech have developed a new sensitive technique capable of detecting colorectal cancer in tissue samples -- a method that could one day be used in clinical settings for the early diagnosis of colorectal cancer.
A study that successfully differentiated patients with pancreatic cancer from those with another pancreatic disease using a new biomarker, could lead to a blood test that detects pancreatic cancer early enough for curative surgery to be feasible.
Patients with diabetes have to control their blood sugar by regularly pricking their finger and giving themselves insulin shots. The procedure is painful and imprecise - injecting the wrong amount of insulin can lead to serious complications, and in some cases, coma and death.
New devices called stent retrievers are enabling physicians to benefit selected patients who suffer strokes caused by blood clots. The devices effectively stop strokes in their tracks.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos